Brisbane biotech firm Ellume puts Australian arm into administration
The Australian arm of a brisbane-based biotech company that struck a $300 million deal to send COVID-19 home testing kits to the US has gone into voluntary administration. A meeting of Ellume’s creditors is to be held later this month. Ellume’s US business is not affected. Ellume rose to prominence last year when it signed…